Outpatient treatment of malignant ascites in patients with advanced gynecologic carcinomas: a single-institution experience with intraperitoneal application of the trifunctional monoclonal antibody catumaxomab

134 - Focused Plenary
Outpatient treatment of malignant ascites in patients with advanced gynecologic carcinomas: a single-institution experience with intraperitoneal application of the trifunctional monoclonal antibody catumaxomab

Monday, March 24, 2014: 4:14 PM

Ballroom B/C (Tampa Convention Center)

C. M. Kurbacher, O. Horn, J. Lepique, C. Schweitzer, S. Herz and J. A. Kurbacher
Gynecological Center Bonn-Friedensplatz, Bonn, Germany